{"url_path":"/sec/inm/8-k/2026-04-27/item-3-03","section_key":"item-3-03","section_title":"Item 3.03 Material Modification to Rights of","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-04-27","source_url":"https://www.sec.gov/Archives/edgar/data/1728328/0001213900-26-048064-index.html","accession_number":"0001213900-26-048064","cik":"0001728328","ticker":"INM","issuer_name":"InMed Pharmaceuticals Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1728328/0001213900-26-048064-index.html","primary_entity_key":"0001728328","primary_entity_name":"InMed Pharmaceuticals Inc."},"word_count":33,"has_tables":true,"body_markdown":"**Item 3.03 Material Modification to Rights of\nSecurity Holders.**\n\n \n\nTo the extent required by Item 3.03 of Form 8-K,\nthe information contained in Item 1.01 of this Report is incorporated by reference herein."}